|
|
40
|
|
|
A681FC
|
|
|
KIVALA 600MG | 300MG TAB (REM/SBI) ABACAVIR | LAMIVUDINE
|
|
|
ABACAVIR|LAMIVUDINE
|
|
|
KIVALA
|
|
|
30'S
|
|
|
BL
|
|
|
82.72
|
|
|
2.76
|
|
|
600MG|300MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
REM
|
|
|
REMEDICA LTD
|
|
|
SBI
|
|
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
08180892
|
|
|
ANTIRETROVIRALS MISCELLANEOUS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|